Page last updated: 2024-09-05

lenalidomide and Cytomegalovirus

lenalidomide has been researched along with Cytomegalovirus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujiwara, T; Fukuhara, N; Furukawa, E; Harigae, H; Ichikawa, S; Kawajiri, A; Nakagawa, R; Onishi, Y; Onodera, K; Saito, K; Sano, S	1

Other Studies

1 other study(ies) available for lenalidomide and Cytomegalovirus

Article	Year
Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma. Annals of hematology, 2019, Volume: 98, Issue:8 Topics: ADP-ribosyl Cyclase 1; Aged; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dexamethasone; Drug Evaluation; Female; Ganciclovir; Humans; Immunocompromised Host; Lenalidomide; Lymphocytes; Male; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Recurrence; Retrospective Studies; Valganciclovir; Virus Activation	2019

Article

Year

Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma.

Annals of hematology, 2019, Volume: 98, Issue:8

Topics: ADP-ribosyl Cyclase 1; Aged; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dexamethasone; Drug Evaluation; Female; Ganciclovir; Humans; Immunocompromised Host; Lenalidomide; Lymphocytes; Male; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Recurrence; Retrospective Studies; Valganciclovir; Virus Activation

2019